# Docetaxel and Loplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced SCCHN

> **NCT03117257** · PHASE2 · UNKNOWN · sponsor: **Guiyang Medical University** · enrollment: 144 (estimated)

## Conditions studied

- Locally Advanced Head and Neck Squamous Cell Carcinoma

## Interventions

- **DRUG:** Lobaplatin
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT03117257
- **Lead sponsor:** Guiyang Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08-19
- **Primary completion:** 2019-08-19
- **Final completion:** 2021-08-20
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2017-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03117257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03117257, "Docetaxel and Loplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced SCCHN". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03117257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*